In a placebo-controlled trial, weekly subcutaneous semaglutide led to larger reductions in BMI (16.1% with semaglutide and +0.6% with placebo), body weight (15.3 kg with semaglutide and +2.4 kg with placebo), waist circumference, glycated hemoglobin levels, lipid parameters (excluding HDL), and alanine aminotransferase at 68 weeks versus placebo [14]
You're trying to keep muscle while losing fat
The HPA axis includes the Hypothalamus (brain region), Pituitary (a gland in the brain), and Adrenals (produces adrenalin and cortisol)
What Can Vitamin B12 Injections Do for You
These behaviors can easily derail the healthy routines you built during GLP-1 treatment and lead to weight gain
In healthy tissue, the peptide maintains NO homeostasis by modestly increasing endothelial NOS (eNOS) for beneficial vasodilation while suppressing inducible NOS (iNOS) that drives pathological inflammation